Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

China FDA Generic Rejections Show Tightening Quality Noose

This article was originally published in PharmAsia News

Executive Summary

The recent rejection of 11 new drug applications by the China FDA is indicative of the country’s increasingly tightening controls over product quality, with a particular focus on generics, and followed the agency’s newly issued generic drug quality guidance designed to ensure the consistent evaluation of generic filings.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC088545

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel